ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 016

Genetic Susceptibility Loci for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Syndrome

Kalpana Manthiram1, Silvia Preite 2, Fatma Dedeoglu 3, Selcan Demir 4, Seza Ozen 5, Kathryn Edwards 6, Sivia Lapidus 7, Alexander Katz 2, Henry Feder 8, Maranda Lawton 3, Greg Licameli 3, Peter Wright 9, Karyl Barron 2, Amanda Ombrello 2, Beverly Barham 2, Tina Romeo 10, Anne Jones 11, Hemalatha Srinivasalu 12, Pamela Mudd 12, Roberta DeBiasi 12, Ahmet Gul 13, Gary Marshall 14, Olcay Jones 15, Yuriy Stepanovskiy 16, Polly Ferguson 17, Pamela Schwartzberg 2, Elaine Remmers 2 and Daniel Kastner 18, 1National Institutes of Health, Bethesda, Maryland, 2National Institutes of Health, Bethesda, 3Boston Children's Hospital, Boston, 4Hacettepe University, Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Ankara, Turkey, 5Hacettepe University, Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, 6Vanderbilt University School of Medicine, Nashville, 7The Joseph M. Sanzari Children's Hospital, Hackensack Meridian Health, Maplewood, 8Connecticut Children's Medical Center, Hartford, 9Dartmouth-Hitchcock Medical Center, Lebanon, 10NIH, Bethesda, 11Bethesda, 12Children's National Medical Center, Washington, 13Istanbul University, Istanbul, Turkey, 14University of Louisville School of Medicine, Louisville, 15Walter Reed National Military Medical Center, Bethesda, 16Shupyk National Medical Academy of Postgraduate Education, Kiev, 17University of Iowa Carver College of Medicine, Iowa City, 18National Human Genome Research Institute, Bethesda

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: aphthous ulcers, Behcet's syndrome, periodic fever, PFAPA

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Breakout 2 – Genetics & Pathogenesis

Session Type: Poster Breakout Session

Session Time: 5:10PM-5:40PM

Background/Purpose: Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome of childhood. Although familial clustering of the disease has been noted, associated genetic variants have not yet been identified and replicated in multiple cohorts. We aimed to identify common genetic variants associated with PFAPA and understand the functional consequences of these variants.

Methods: We genotyped 2 cohorts of European-American and one cohort of Turkish individuals with PFAPA (total N=231) for common genetic variants previously associated with two other ulcerative diseases, Behçet’s disease and recurrent aphthous stomatitis. We compared the genotypes of these variants among PFAPA patients to the frequencies reported in large databases (gnomAD, ALSPAC). We also imputed HLA alleles from genotyping data in the MHC region and compared the frequency of these alleles to those among European-American and Turkish controls. In order to understand the functional significance of these variants, we obtained tonsils from children undergoing tonsillectomy with PFAPA syndrome (N=12) and with structural oropharyngeal disorders (N=10). Mononuclear cells from the tonsils were separated by standard methods and cells were analyzed by flow cytometry and gene expression with Nanostring. Cytokine production by isolated tonsillar mononuclear cells was measured by flow cytometry following phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation for 4 hours ex vivo. We obtained peripheral blood from individuals from the National Institutes of Health Blood Bank and The Genomic Ascertainment Cohort with and without the IL12A risk variant, isolated CD14+ monocytes by magnetic-activated cell sorting, and measured IL-12p70 production by ELISA after stimulation with IFNγ and LPS for 8 hours. 

Results: We found that the rs17753641 variant upstream of IL12A is strongly associated with PFAPA in all three cohorts (ORmeta of 2.13, pmeta=6×10-9) and is associated with elevated IL-12p70 production by CD14+ monocytes upon stimulation with IFNγ and LPS. We also found that variants near STAT4, IL10, and CCR1-CCR3 were significant susceptibility loci for PFAPA. In addition, we identified class I and class II HLA risk alleles for PFAPA including HLA-DRB1*1301, HLA-DQA1*0103, HLA-DQB1*0603, HLA-B*1501, and HLA-B*3502. In the tonsils, we found that CD4+ T cells of patients with PFAPA have increased expression of Th1 and Th17-related genes. Moreover, upon stimulation with PMA and ionomycin, CD4+ effector T cells in PFAPA tonsils produce more IFNγ and IL-17 than controls.

Conclusion: We identify genetic risk variants and HLA risk alleles for PFAPA that replicate in multiple cohorts. Because the non-HLA risk variants are also associated with Behçet’s disease and recurrent aphthous ulcers, we propose to group these three diseases as a family called Behçet’s spectrum disorders (BSD) to highlight the overlap in their pathogenesis. HLA may be a factor that influences phenotype along this spectrum. The genetic variants and tonsil CD4+ T cell profile we found suggest that PFAPA is a disorder of dysregulated antigen-presenting cell function and heightened Th1 and Th17 cell activation.


Disclosure: K. Manthiram, None; S. Preite, None; F. Dedeoglu, Novartis, 1, UptoDate, 1; S. Demir, None; S. Ozen, None; K. Edwards, Pfizer, 1, Sanofi, 1, Moderna, 1, X-4 Pharma, 1; S. Lapidus, None; A. Katz, None; H. Feder, None; M. Lawton, None; G. Licameli, None; P. Wright, None; K. Barron, None; A. Ombrello, None; B. Barham, None; T. Romeo, None; A. Jones, None; H. Srinivasalu, None; P. Mudd, None; R. DeBiasi, None; A. Gul, None; G. Marshall, None; O. Jones, None; Y. Stepanovskiy, None; P. Ferguson, None; P. Schwartzberg, None; E. Remmers, None; D. Kastner, None.

To cite this abstract in AMA style:

Manthiram K, Preite S, Dedeoglu F, Demir S, Ozen S, Edwards K, Lapidus S, Katz A, Feder H, Lawton M, Licameli G, Wright P, Barron K, Ombrello A, Barham B, Romeo T, Jones A, Srinivasalu H, Mudd P, DeBiasi R, Gul A, Marshall G, Jones O, Stepanovskiy Y, Ferguson P, Schwartzberg P, Remmers E, Kastner D. Genetic Susceptibility Loci for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Syndrome [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/genetic-susceptibility-loci-for-periodic-fever-aphthous-stomatitis-pharyngitis-and-cervical-adenitis-pfapa-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-susceptibility-loci-for-periodic-fever-aphthous-stomatitis-pharyngitis-and-cervical-adenitis-pfapa-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology